Study of Paclitaxel in Combination With BOS172722 in Patients With Advanced Nonhaematologic Malignancies
Clinical trial NCT03328494 · COMPLETED
Trial details
- NCT number
- NCT03328494
- Sponsor
- Boston Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-13
- Primary completion
- 2021-03-16
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.